Lewy bodies and Lewy neurites in the brain constitute the main histopathological features of
Parkinson's disease (PD) and dementia with Lewy bodies. They comprise amyloid-like fibrils …

Alzheimer's disease (AD) is one of the most devastating neurodegenerative diseases in
modern society because of insurmountable difficulties in early diagnosis and lack of …

Dementia with Lewy bodies (DLB) is characterized by widespread depositions of α-
synuclein, which are described as Lewy bodies. Recently, it was shown that neuronal cells …

Characteristic tau isoform composition of the insoluble fibrillar tau inclusions define
tauopathies, including Alzheimer's disease (AD), progressive supranuclear palsy (PSP) and …

Alpha‐synuclein (α‐S yn) is a central player in Parkinson's disease (PD) and in a spectrum
of neurodegenerative diseases collectively known as synucleinopathies. The protein was …

The α-synuclein aggregation in the brain is the hallmark of Lewy body diseases, including
Parkinson's disease and dementia with Lewy bodies, and multiple system atrophy. Some …

Lewy bodies (LBs) and Lewy neurites (LNs) in the brain constitute the main
histopathological features of Parkinson's disease (PD) and dementia with Lewy bodies …

More than 750,000 of the UK population suffer from some form of cognitive impairment and
dementia. Of these, 5–20% will have Dementia with Lewy Bodies (DLB). Clinico …

The aggregation of α-synuclein (αS) in the central nervous system (CNS) is the hallmark of
multiple system atrophy (MSA) and Lewy body diseases including Parkinson's disease (PD) …

It is well known that oligomeric/aggregated amyloid β peptides are a key player in the
pathogenesis of Alzheimer's disease and that different nanoparticles influence …